Ximei Shen

795 total citations
44 papers, 609 citations indexed

About

Ximei Shen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Ximei Shen has authored 44 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Ximei Shen's work include Pancreatic function and diabetes (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Ximei Shen is often cited by papers focused on Pancreatic function and diabetes (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Ximei Shen collaborates with scholars based in China. Ximei Shen's co-authors include Sunjie Yan, Yongze Zhang, Liyong Yang, Fengying Zhao, Lili Yu, Jihong Shao, Sunjie Yan, Peiwen Wu, Rongrong Yang and Huanhuan Zheng and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Life Sciences and Metabolism.

In The Last Decade

Ximei Shen

40 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ximei Shen China 15 214 202 180 126 75 44 609
Luca D’Onofrio Italy 19 282 1.3× 235 1.2× 291 1.6× 147 1.2× 122 1.6× 52 1.1k
Melek Eda Ertörer Türkiye 16 167 0.8× 404 2.0× 148 0.8× 137 1.1× 85 1.1× 50 795
Jin Ook Chung South Korea 14 117 0.5× 212 1.0× 256 1.4× 109 0.9× 174 2.3× 64 718
A Cohen Canada 9 187 0.9× 88 0.4× 135 0.8× 92 0.7× 52 0.7× 12 575
Sang Ah Lee South Korea 13 93 0.4× 227 1.1× 138 0.8× 235 1.9× 84 1.1× 44 736
Noriyuki Kitagawa Japan 14 245 1.1× 96 0.5× 86 0.5× 103 0.8× 115 1.5× 74 622
Mehmet Çalan Türkiye 13 110 0.5× 96 0.5× 117 0.7× 75 0.6× 81 1.1× 56 573
Sinem Kıyıcı Türkiye 16 77 0.4× 250 1.2× 159 0.9× 122 1.0× 67 0.9× 38 732
Eu Jeong Ku South Korea 17 178 0.8× 362 1.8× 251 1.4× 245 1.9× 113 1.5× 69 860
Charles C. White United States 14 192 0.9× 231 1.1× 77 0.4× 312 2.5× 110 1.5× 26 822

Countries citing papers authored by Ximei Shen

Since Specialization
Citations

This map shows the geographic impact of Ximei Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ximei Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ximei Shen more than expected).

Fields of papers citing papers by Ximei Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ximei Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ximei Shen. The network helps show where Ximei Shen may publish in the future.

Co-authorship network of co-authors of Ximei Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ximei Shen. A scholar is included among the top collaborators of Ximei Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ximei Shen. Ximei Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shaoming, Xiaodong Li, Fei Lin, et al.. (2025). Total or partial adrenalectomy for aldosterone-producing adenoma: can 68Ga-Pentixafor PET/CT predict surgical outcomes?. European Journal of Nuclear Medicine and Molecular Imaging. 52(10). 3632–3642. 3 indexed citations
2.
Tao, Bei, Ximei Shen, Guangfei Li, et al.. (2025). New Evidence, Creative Insights, and Strategic Solutions: Advancing the Understanding and Practice of Diabetes Osteoporosis. Journal of Diabetes. 17(4). e70091–e70091. 2 indexed citations
3.
Shen, Ximei, et al.. (2025). TLR4 mediates glucolipotoxicity-induced mitochondrial dysfunction in osteoblasts by enhancing NLRP3-MAVS expression and interaction. International Immunopharmacology. 153. 114438–114438. 1 indexed citations
6.
Zhang, Yongze, et al.. (2021). Relationship between Hyponatremia and Peripheral Neuropathy in Patients with Diabetes. Journal of Diabetes Research. 2021. 1–11. 8 indexed citations
7.
Liang, Bo, et al.. (2021). Glycolipid toxicity induces osteogenic dysfunction via the TLR4/S100B pathway. International Immunopharmacology. 97. 107792–107792. 9 indexed citations
8.
Shen, Ximei, et al.. (2021). The Value of Ketone Bodies in the Evaluation of Kidney Function in Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2021. 1–8. 6 indexed citations
9.
Hong, Xinyu, et al.. (2021). Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes. Kidney & Blood Pressure Research. 46(5). 550–562. 4 indexed citations
10.
Shen, Ximei, et al.. (2020). Exendin‑4 inhibits lipotoxicity‑induced oxidative stress in β‑cells by inhibiting the activation of TLR4/NF‑κB signaling pathway. International Journal of Molecular Medicine. 45(4). 1237–1249. 9 indexed citations
11.
Zhang, Yongze, Ximei Shen, Lanlan He, Fengying Zhao, & Sunjie Yan. (2020). Association of sarcopenia and muscle mass with both peripheral neuropathy and nerve function in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 162. 108096–108096. 18 indexed citations
12.
Shen, Ximei, et al.. (2019). Metformin Reduces Lipotoxicity-Induced Meta-Inflammation in β-Cells through the Activation of GPR40-PLC-IP3 Pathway. Journal of Diabetes Research. 2019. 1–16. 15 indexed citations
13.
Yan, Sunjie, et al.. (2019). TLR4 knockout can improve dysfunction of β-cell by rebalancing proteomics disorders in pancreas of obese rats. Endocrine. 67(1). 67–79. 18 indexed citations
14.
Chen, Chao, et al.. (2019). TAK-875 Mitigates β-Cell Lipotoxicity-Induced Metaflammation Damage through Inhibiting the TLR4-NF-κB Pathway. Journal of Diabetes Research. 2019. 1–11. 13 indexed citations
15.
Zhang, Yongze, Ximei Shen, Ling Cheng, et al.. (2019). Toll-like receptor 4 knockout protects against diabetic-induced imbalance of bone metabolism via autophagic suppression. Molecular Immunology. 117. 12–19. 19 indexed citations
17.
Yang, Liyong, et al.. (2015). Relationship between glycated hemoglobin A1c and cognitive function in nondemented elderly patients with type 2 diabetes. Metabolic Brain Disease. 31(2). 347–353. 14 indexed citations
18.
Yang, Liyong, et al.. (2013). HbA1c in the diagnosis of diabetes and abnormal glucose tolerance in patients with Graves’ hyperthyroidism. Diabetes Research and Clinical Practice. 101(1). 28–34. 12 indexed citations
19.
20.
Wu, Peiwen, Liyong Yang, & Ximei Shen. (2010). The relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazone. Biochemical and Biophysical Research Communications. 403(1). 36–39. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026